In contrast with gastric cancer little is known about the biological behaviour and prognosis of signet-ring cells (SRC). To clarify the biological behaviour of oesophageal signet-ring-cell containing carcinomas (SRC), clinicopathological features were compared to non-SRC adenocarcinomas (ADC) of the oesophagus and gastro-oesophageal-junction (GEJ). Between 1990 and 2009, 779 patients underwent primary R0 resection. Specimens containing signet-ring cells were classified according to WHO criteria (>50% SRC or 50% SRC, 57 P < 0.001). In SRC 50% it was 16% (NS). Lymph node metastasis (pN+) was present in 438 patients with cancer-specific 5-year survival of 32% in ADC, 29% in SRC 50% (P = 0.010). The mean number of positive lymph nodes was not significantly different between ADC and SRC 50% (5.85 vs 8.89; P = 0.049). In ADC, 30% were pN3s (>6 positive LNs), not significantly different from pN3s in SRC 50% (61%, P = 0.006). SRC showed a higher recurrence rate (56% vs 42% for ADC; P = 0.003) in particular locoregional recurrences (29% vs 16%; P = 0.002). Locoregional recurrence was more prominent in SRC >50% (44%) vs SRC 50% (sensitivity = 60%, PPV = 50%). SRC are aggressive neoplasms carrying a worse prognosis compared to non-SRC ADC after primary oesophagectomy, which appears mainly related to the SRC >50% subgroup because of higher nodal stage (pN3) and increased locoregional recurrence, whereas pN + SRC 50%, presence of signet-ring cells in pre-treatment biopsies appear to be of no use to define treatment strategy or prognosis. All authors have declared no conflicts of interest.